Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt), sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate and N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine (76741-94-1)

Other Product

• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
• Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, hydrochloride, mixt. with (7S-(7alpha,7aalpha,14alpha,14abeta))-dodecahydro-7,14-methano-2H,6H-dipyrido(1,2-a:1,2-e)(1,5)diazocine sulfate (1:1) and endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl-alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt)
• Ethanaminium, 2-(1-bicyclo(2.2.1)hept-5-en-2-yl-1-phenylethoxy)-N,N-diethyl-N-methyl-, bromide, mixt. with 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol (5alpha,6alpha)-, phosphate (1:1) (salt), and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid and N-(4-ethoxyphenyl)acetamide
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,hydrochloride,(5R,6R)-,mixt. with 10-[(dimethylamino)acetyl]-10Hphenothiazine,(3-endo)-3-[(hydroxyphenylacetyl) oxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]- octane bromide and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, hydrochloride, (5alpha,6alpha)-, mixt. with (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2,4))non-7-yl alpha-(hydroxymethyl)benzeneacetate hydrobromide and sodium (1S)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methane sulfonate
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with (R*,S*)-(+-)-alpha-(1-aminoethyl)benzenemethanol and N-(4-hydroxyphenyl)acetamide
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one, 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride, 2-methyl-2-propyl-1,3-propanediyl dicarbamate and 3-pyridinecarboxylic acid
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1-1) (salt), mixture with sodium 1,4-bis(2-ethylhexyl) sulfobutanedioate, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)piperazine dihydrochloride & N-(4-hydroxyphenyl)acetamide
• 8-Azoniabicyclo[3.2.1]octane,3-(3-hydroxy-1- oxo-2-phenylpropoxy)-8,8-dimethyl-,(3- endo)-,nitrate (salt),mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline hydrochloride and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:2)
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, N-(aminocarbonyl)-2-bromo-2-ethylbutanamide, N-(aminocarbonyl)-2-bromo-3-methylbutanamide, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and N-(4-hydroxyphenyl)acetamide
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate (1:1) (salt), mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride
• 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:1)
• Pyridinium,2-[(hydroxyimino)methyl]-1- methyl-,iodide,mixt. with 2-(diethylamino)ethyl R-hydroxy-R-phenylbenzeneacetate and (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate
• 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2-oxo-1-phenyl-, endo-, (E)-2-butenedioate, hydrate (1:1:2) (salt)
• Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 2-(acetyloxy)benzoic acid and N-(4-hydroxyphenyl)acetamide